Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis.

Hou MM, Li YF, He LL, Li XQ, Zhang Y, Zhang SX, Li XY.

Int Immunopharmacol. 2019 Oct;75:105793. doi: 10.1016/j.intimp.2019.105793. Epub 2019 Aug 8.

PMID:
31401379
2.

Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.

Wei Y, Chang H, Li X, Wang H, Du L, Zhou H, Xu W, Ma Y, Yin L, Zhang X.

Neuroimmunomodulation. 2018;25(4):215-224. doi: 10.1159/000494976. Epub 2018 Dec 13.

PMID:
30544111
3.

Th17 cells in neuromyelitis optica spectrum disorder: a review.

Lin J, Li X, Xia J.

Int J Neurosci. 2016 Dec;126(12):1051-60. doi: 10.3109/00207454.2016.1163550. Epub 2016 Apr 1. Review.

PMID:
26954363
4.

Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: A meta-analysis.

Li YF, Zhang SX, Ma XW, Xue YL, Gao C, Li XY.

Mult Scler Relat Disord. 2017 Nov;18:20-25. doi: 10.1016/j.msard.2017.09.003. Epub 2017 Sep 13. Review.

PMID:
29141810
5.

Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.

Wang Y, Zhou Y, Sun X, Lu T, Wei L, Fang L, Chen C, Huang Q, Hu X, Lu Z, Peng L, Qiu W.

Neuroimmunomodulation. 2016;23(5-6):352-358. doi: 10.1159/000464135. Epub 2017 Apr 27.

PMID:
28445879
6.

Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.

Zhang Y, Yao XY, Gao MC, Ding J, Hong RH, Huang H, Zhuang L, Wang YG, Hao Y, Guan YT.

CNS Neurosci Ther. 2018 Jan;24(1):64-69. doi: 10.1111/cns.12774. Epub 2017 Nov 6.

7.

Resolution of inflammation in neuromyelitis optica spectrum disorders.

Wang X, Jiao W, Lin M, Lu C, Liu C, Wang Y, Ma D, Wang X, Yin P, Feng J, Zhu J, Zhu M.

Mult Scler Relat Disord. 2019 Jan;27:34-41. doi: 10.1016/j.msard.2018.09.040. Epub 2018 Oct 2.

PMID:
30300851
8.

Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients.

Barros PO, Dias ASO, Kasahara TM, Ornelas AMM, Aguiar RS, Leon SA, Ruiz A, Marignier R, Araújo ACRA, Alvarenga R, Bento CAM.

J Neuroimmunol. 2017 Jun 15;307:82-90. doi: 10.1016/j.jneuroim.2017.04.001. Epub 2017 Apr 7.

PMID:
28495144
9.

Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.

Kong BS, Kim Y, Kim GY, Hyun JW, Kim SH, Jeong A, Kim HJ.

J Neuroinflammation. 2017 Sep 25;14(1):191. doi: 10.1186/s12974-017-0961-z.

10.

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

Chen H, Liu SM, Zhang XX, Liu YO, Li SZ, Liu Z, Dong HQ.

Chin Med J (Engl). 2016 Sep 5;129(17):2079-84. doi: 10.4103/0366-6999.189046.

11.

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.

Yamashita K, Kinoshita M, Miyamoto K, Namba A, Shimizu M, Koda T, Sugimoto T, Mori Y, Yoshioka Y, Nakatsuji Y, Kumanogoh A, Kusunoki S, Mochizuki H, Okuno T.

J Neuroinflammation. 2018 Apr 27;15(1):125. doi: 10.1186/s12974-018-1162-0.

12.

Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.

Gao M, Yao X, Ding J, Hong R, Wu Y, Huang H, Zhuang L, Li Z, Wang Y, Zhang Y, Guan Y.

J Clin Neurosci. 2019 Mar;61:22-27. doi: 10.1016/j.jocn.2018.11.024. Epub 2019 Jan 25.

PMID:
30692037
13.

Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission.

Tong Y, Yang T, Wang J, Zhao T, Wang L, Kang Y, Cheng C, Fan Y.

Front Neurol. 2018 Feb 12;9:44. doi: 10.3389/fneur.2018.00044. eCollection 2018.

14.

Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders.

Yang H, Han L, Zhou YJ, Ding J, Cai Y, Hong RH, Hao Y, Zhu DS, Shen XF, Guan YT.

CNS Neurosci Ther. 2019 Jul 24. doi: 10.1111/cns.13198. [Epub ahead of print]

PMID:
31342670
15.

Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity.

Song Y, Zhu M, Liu C, Zheng C, Zhou Y, Zhu J, Jin T.

Immunobiology. 2019 May;224(3):397-401. doi: 10.1016/j.imbio.2019.02.008. Epub 2019 Mar 1.

PMID:
30852049
16.

Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Shimizu J, Takai K, Takada E, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Suzuki T, Suzuki N.

Clin Rheumatol. 2016 Jul;35(7):1857-63. doi: 10.1007/s10067-015-2966-2. Epub 2015 May 14.

PMID:
25972082
17.

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ.

J Clin Neurosci. 2011 Oct;18(10):1313-7. doi: 10.1016/j.jocn.2011.01.031. Epub 2011 Jul 26.

PMID:
21795048
18.

Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.

Yang CS, Zhang QX, Deng Y, Zhou BJ, Zhang LJ, Li LM, Qi Y, Wang J, Yang L, Shi FD.

BMC Neurol. 2019 Aug 5;19(1):185. doi: 10.1186/s12883-019-1415-2.

19.

Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.

Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A.

Mult Scler Relat Disord. 2019 Jan;27:350-363. doi: 10.1016/j.msard.2018.11.008. Epub 2018 Nov 16. Review.

PMID:
30476871
20.

Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.

Brill L, Lavon I, Vaknin-Dembinsky A.

Mult Scler Relat Disord. 2019 May;30:114-118. doi: 10.1016/j.msard.2019.01.047. Epub 2019 Jan 30. Erratum in: Mult Scler Relat Disord. 2019 May;30:291.

PMID:
30771576

Supplemental Content

Support Center